CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Tianjin Lisheng Pharmaceutical Company Limited Company Snapshot
Tianjin Lisheng Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Lisheng Pharmaceutical Company Limited with three other companies in this sector in China: Changzhou Qianhong Biopharma Co., Ltd. (2017 sales of 1.07 billion Chinese Renmimbi [US$154.87 million] of which 100% was Bio-pharmaceutical Industry), Lionco Pharmaceutical Group Co Ltd (1.01 billion Chinese Renmimbi [US$146.09 million] of which 38% was Anti-Infection), and Betta Pharmaceuticals Co Ltd (1.03 billion Chinese Renmimbi [US$149.18 million] of which 100% was Icotinib Hydrochloride Tablets).

Sales Analysis. During the year ended December of 2017, sales at Tianjin Lisheng Pharmaceutical Company Limited were 1.03 billion Chinese Renmimbi (US$149.63 million). This is an increase of 21.6% versus 2016, when the company's sales were 846.83 million Chinese Renmimbi. This was the third consecutive year of growth at Tianjin Lisheng Pharmaceutical Company Limited. The sales level in 2017 was fairly close to the level five years ago: in 2012, Tianjin Lisheng Pharmaceutical Company Limited had sales of 1.12 billion Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tianjin Lisheng Pharmaceutical Company Limited
  Stock Performance Chart for Tianjin Lisheng Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (12/14/2018): 21.10
(Figures in Chinese Renmimbi)
1 Week -3.5%   13 Weeks -9.0%  
4 Weeks -4.4%   52 Weeks -34.6%  
 
Tianjin Lisheng Pharmaceutical Company Limited Key Data:
  Ticker: 002393 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 1,029,433,431
(Year Ending Jan 2018).
Employees: 1,692
  Currency: Chinese Renmimbi Market Cap: 3,849,800,331
  Fiscal Yr Ends: December Shares Outstanding: 182,454,992
  Share Type: A Gu Closely Held Shares: 103,300,193
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.